| LINE ITEM (USD / %) | FY 2025
FILED 2026-02-28 | FY 2024
FILED 2025-03-01 | FY 2023
FILED 2024-03-02 |
|---|---|---|---|
| Revenue (Total Sales) | $1.40B | $1.36B | $1.42B |
| YoY Revenue Growth % | +3.2% | -3.9% | — |
| Gross Profit | $319.5M | $359.9M | — |
| Gross Margin % | 22.7% | 26.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $84.5M | $118.1M | $133.8M |
| Operating Margin % | 6.0% | 8.7% | 9.4% |
| Net Income (GAAP) | $54.1M | $85.1M | $99.6M |
| EBITDA (Normalized) | $106.3M | $146.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $122.5M | $125.2M | $204.2M |
| Capital Expenditures (CapEx) | $27.3M | $35.6M | — |
| Free Cash Flow (FCF) | $95.2M | $89.6M | $204.2M |
| FCF Margin % | 6.8% | 6.6% | 14.4% |
| Return on Invested Capital (ROIC %) | 9.2% | 12.4% | — |
| Cash & Short-Term Equivalents | $41.3M | $43.9M | — |
| Total Debt (Short + Long Term) | $255.0M | $272.0M | — |
| Total Stockholders' Equity | $512.3M | $522.1M | — |